Matthew P. Blischak

Insider Reports History

Location
Somerville, MA
Signature
By: /s/ Matthew P. Blischak
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Matthew P. Blischak:

Company Role Class Num Shares Value Price $ Report Date Ownership
Finch Therapeutics Group, Inc. Chief Executive Officer Stock Option (right to buy) 962,899 09 Jun 2023 Direct

Insider Reports Filed by Matthew P. Blischak

Symbol Company Period Transactions Value $ Form Type Role Filing Time
FNCH Finch Therapeutics Group, Inc. 09 Jun 2023 1 $0 4/A Chief Executive Officer 23 Jun 2023, 16:30
FNCH Finch Therapeutics Group, Inc. 08 Jun 2023 1 $0 4 Chief Executive Officer 09 Jun 2023, 16:52
FNCH Finch Therapeutics Group, Inc. 16 May 2023 0 $0 3 Chief Executive Officer 16 May 2023, 16:17